| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267395.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027059681 |
Resistant |
| ENSG00000267395.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036011978 |
Sensitive |
| ENSG00000267395.1 |
Ponatinib |
Stomach adenocarcinoma |
0.047727763 |
Sensitive |
| ENSG00000267395.1 |
Ponatinib |
Skin cutaneous melanoma |
0.025794017 |
Sensitive |
